Quercus Brantii Lindl. Vaginal Douche Versus Clotrimazole on Vaginal Candidiasis - a Randomized Clinical Trial

Total Page:16

File Type:pdf, Size:1020Kb

Quercus Brantii Lindl. Vaginal Douche Versus Clotrimazole on Vaginal Candidiasis - a Randomized Clinical Trial ISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2018;21[3]:185-194 DOI: https://doi.org/10.3831/KPI.2018.21.022 Original article Quercus Brantii Lindl. Vaginal Douche Versus Clotrimazole on Vaginal Candidiasis - A Randomized Clinical Trial - Zeinab Moshfeghy1,2 *, Khadegeh Asadi2, Marzieh Akbarzadeh3, Atefeh Zare2, Ta- hereh Poordast4,5, Masoumeh Emamghoreishi6, Fatemeh S.Najib4,5, Mehrab Saya- di7 1 Community Based Psychiatric Care Center, Shiraz University of Medical Sciences, Shiraz, Iran 2 Department of Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran 3 Maternal-Fetal Research Center, Department of Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran 4 Infertility Research Center, Shiraz University of Medical Science, Shiraz, Iran 5 Department of OB/GYN, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 6 Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 7 Cardio-vascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Key Words vaginal douche of Q. Brantii extract. Groups were treat- ed for 7 days and KOH tests and cultures were evaluat- clotrimazole vaginal cream, extract, Quercus Brantii ed again. Data were analyzed via chi-square and inde- Lindl., Vaginal Candidiasis, vaginal douche pendent t-test, using SPSS software. Results: According to the results, there were no sig- Abstract nificant differences between experimental groups for demographic characteristics like age (p=0.403), BMI Objectives: Vaginal Candidiasis with an approximate (p=0.911), educational levels (p=0.862) and contra- prevalence of 30% is the second cause of vaginal infec- ceptive methods (p=0.702). Moreover, significant dif- tions. Antifungal azole is the first treatment forVaginal ferences were seen in vaginal discharge between the Candidiasis; however, some side effects have been re- groups after the treatments (P=0.043). ported for this chemical medicine. Based on the anti- fungal activity of Inner Stratum of Quercus Brantii (Q. Conclusion: The results suggested that the therapeu- Brantii), the aim of our study was to compare the effects tic effect of vaginal douche ofQ. Brantii extract was of vaginal douche of Q. Brantii extract and clotrimazole approximately similar to that of clotrimazole vaginal on vaginal candidiasis symptoms before and after the cream. treatments, in women. Methods: 89 non-pregnant women with positive KOH 1. Introduction test which is capable of identifying the presence of hy- phae and mycelium by adding KOH (10%), and a posi- Vaginal candidiasis is one of the most frequent infec- tive vaginal candidiasis culture were randomly divided tions of the female genital tract [1]. Vaginal candidiasis into two experimental groups, using permuted block is the second most common cause of vaginitis world- randomization method. One group received clotrima- wide, after the bacterial infection. The risk of vaginal zole vaginal cream (1%) and the other group received candidiasis for non-pregnant women is approximately 20%, but it increases by 30% during pregnancy [2]. No Received: Feb 11, 2018 Reviewed: Jul 11, 2018 Accepted: Aug 02, 2018 complete reporting of the number of women involved This is an Open-Access article distributed under the terms of the Creative Commons *Corresponding Author Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) Zeinab Moshfeghy. Community Based Psychiatric Care Research Center, Department of which permits unrestricted noncommercial use, distribution, and reproduction in any Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, medium, provided the original work is properly cited. Shiraz, Iran. Tel: +98-713-647-4256 Fax: +98-713-647-4252 This paper meets the requirements of KS X ISO 9706, ISO 9706-1994 and ANSI/NISO E-mail: [email protected] Z39.48-1992 (Permanence of Paper). ⓒ 2018 Korean Pharmacopuncture Institute http://www.journal.ac 186 http://www.journal.ac Journal of Pharmacopuncture 2018;21(3):185-194 in Candida vaginitis is available in Iran [3], but according investigation aimed at comparing the effects of two treat- to a study, the prevalence of vaginal candidiasis in Iran is ments, including vaginal douche of Q. Brantii extract and between 25% and 45% [4]. The main reasons for the re- clotrimazole vaginal cream (1%) on vaginal candidiasis currence of Candida are not fully understood [5]. Autoim- symptoms before and after the treatments in women. mune diseases, endocrine diseases, diabetes mellitus, and antibiotic therapy are the main causes of vaginal candidia- sis [6]. The typical symptoms ofvaginal candidiasis include pruritus, vaginal soreness, dyspareunia, external dysuria, 2. Materials and Methods and abnormal vaginal discharge [7]. Patients may be occa- sionally found to have candida based on a culture or Pap smear [8]. Vulvovaginal candidias is as an acute inflam- 2.1. Patients matory disease, caused by Candida sp. especially C. albi- cans through non-albicans species of Candida (C.glabrata, This research was a randomized, case-controlled clini- C.tropicalis and C.dubliniensis) are also associated with cal trial. In this study, 89 non-pregnant women, who had recurrent diseases. Candidiasis is associated with intense a positive KOH test and culture of vaginal candidiasis and pruritus, itching, dyspareunia, erythematous vulva, and had been referred to the gynecology clinics of Shiraz Uni- cottage cheese like discharges, positive vaginal smear and versity of Medical Sciences during 2016 were included culture, and a vaginal pH of less than 4.5. However, non-al- into the study. To select the samples, convenience sam- bicans species are usually less sensitive to azole antifun- pling were utilized and then we divided the patients into gal agents [9,10]. Antifungal azole drugs provide the first 2 groups based on the inclusion criteria of being married treatments for vaginal candidiasis. Nevertheless, some and having an age of 18-49 years and symptoms of vaginal side effects have been reported for this chemical medicine. candidiasis, respectively [22]. All the women were investi- Over-the-counter (OTC) of miconazole and clotrimazole gated for vaginal edema and erythema and other clinical medications for 7 days would provide a proper first-line symptoms of vaginal candidiasis. Also, only single sexual therapy for women with occasional yeast vaginitis [11]. partners married to their respective spouses were chosen Several topical and oral antifungals such as clotrimazole [3]. Other inclusion criteria were: having no abnormal vag- is used for the treatment of vaginal candidiasis [12]. Never- inal or uterine bleeding, no known sensitivity to clotrima- theless, some side effects, such as changes in hepatic en- zole or other herbal drugs including Q. Brantii or known zymes, painful urination, depression, irritation, and der- autoimmune diseases. Those women who were pregnant, matitis have been reported for clotrimazole [13]. Although had pelvic inflammatory diseases and lactation during the it has no side effects during pregnancy, it is associated with study, had menstruated during the study, and had taken embryotoxic effects. Thus, it should be consumed with hormone therapy, vaginal creams at least 7 days before the caution during breast-feeding [14]. Also, the long-term use study, and anti-inflammatory, anti-fungal, and immuno- of antifungal drugs would lead to recurrent vaginitis [11]. suppressive drugs 14 days before the study were excluded Unavailability and high costs of the drugs in low-income from the research. All the patients signed an agreement societies, as well as their probable side effects and resist- form before participating in the investigation and after be- ances have resulted in increased worries about synthetic ing informed about the study procedure [3]. The two codes chemicals [15]. In recent years, people have shown a grow- of A and B, which respectively represented the treatments ing interest in the general trends of natural remedies and with clotrimazole vaginal cream (1%) and vaginal douche herbal therapies when considering the lower costs, high of Q. Brantii, were written on small pieces of paper and put availabilities, and lower side effects of plants and plant- into the relevant patients’ pockets. The women were ran- based chemicals [16]. domly divided into 2 experimental groups by permuted Since long time ago, plants have been used in traditional block randomization method. Group A (n=45) received medicine practiced in almost all Asian countries including clotrimazole vaginal cream (1%) and group B (n=44) re- Iran. Herbal medicine still plays an essential role in various ceived vaginal douche of Q. Brantii. The women in group A therapeutic fields, though synthetic applications of drugs used a clotrimazole vaginal cream (1%) via a vaginal drug in modern medicine have advanced over the past decades. applicator for 7 nights, while those in group B dissolved the In fact, the interest in herbal medications has been raised extract of Q. Brantii in 150 cc of distilled water to use vag- due to the therapeutic properties of plants. Several stud- inal douche of Q. Brantii for 7 nights. They were informed ies have revealed that plants have great amounts of natural to lie on their backs for 30 minute after applying both the antioxidants, as well as large anti-inflammatory [17], anti- vaginal cream and douche. bacterial [18], and antiviral
Recommended publications
  • Chapter 6—Clove Oil (Eugenol)
    Chapter 6—Clove Oil (Eugenol) OH CH3 O Eugenol Chapter 6: Clove oil 6-2 6 Table of Contents — Clove Oil (Eugenol) 6.1 INTRODUCTION ......................................................................................................................................... 6-4 6.2 CLOVE OIL AND EUGENOL TOXICITY TO HUMANS AND LEVELS OF CONCERN ................ 6-6 6.2.1 HEALTH EFFECTS ...................................................................................................................................... 6-7 6.2.1.A Acute Effects—Sensitization ........................................................................................................... 6-7 6.2.1.B Acute Effects—Skin, Eyes and Respiratory System ........................................................................ 6-7 6.2.1.C Acute Effects—Systemic Poisoning ................................................................................................ 6-7 6.2.1.D Effects in Human Cells .................................................................................................................... 6-8 6.2.1.E Levels of Concern for Humans ........................................................................................................ 6-8 6.2.2 PESTICIDE ILLNESS REPORTS .................................................................................................................... 6-9 6.3 EUGENOL TOXICITY TO ANIMALS AND PLANTS AND LEVELS OF CONCERN .................... 6-10 6.3.1 MAMMALS .............................................................................................................................................
    [Show full text]
  • Understanding and Managing the Transition Using Essential Oils Vs
    MENOPAUSE: UNDERSTANDING AND MANAGING THE TRANSITION USING ESSENTIAL OILS VS. TRADITIONAL ALLOPATHIC MEDICINE by Melissa A. Clanton A thesis submitted in partial fulfillment of the requirements for the Diploma of Aromatherapy 401 Australasian College of Health Sciences Instructors: Dorene Petersen, Erica Petersen, E. Joy Bowles, Marcangelo Puccio, Janet Bennion, Judika Illes, and Julie Gatti TABLE OF CONTENTS List of Tables and Figures............................................................................ iv Acknowledgments........................................................................................ v Introduction.................................................................................................. 1 Chapter 1 – Female Reproduction 1a – The Female Reproductive System............................................. 4 1b - The Female Hormones.............................................................. 9 1c – The Menstrual Cycle and Pregnancy....................................... 12 Chapter 2 – Physiology of Menopause 2a – What is Menopause? .............................................................. 16 2b - Physiological Changes of Menopause ..................................... 20 2c – Symptoms of Menopause ....................................................... 23 Chapter 3 – Allopathic Approaches To Menopausal Symptoms 3a –Diagnosis and Common Medical Treatments........................... 27 3b – Side Effects and Risks of Hormone Replacement Therapy ...... 32 3c – Retail Cost of Common Hormone Replacement
    [Show full text]
  • The Effects of Eugenol, Trans-Cinnamaldehyde, Citronellol
    molecules Article The Effects of Eugenol, Trans-Cinnamaldehyde, Citronellol, and Terpineol on Escherichia coli Biofilm Control as Assessed by Culture-Dependent and -Independent Methods Magdalena A. Olszewska 1,* , Astrid G˛edas 1 and Manuel Simões 2,* 1 Department of Industrial and Food Microbiology, Faculty of Food Science, University of Warmia and Mazury in Olsztyn, Plac Cieszy´nski1, 10-726 Olsztyn, Poland; [email protected] 2 LEPABE–Department of Chemical Engineering, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal * Correspondence: [email protected] (M.A.O.); [email protected] (M.S.); Tel.: +48-89-5233729 (M.A.O.); +351-22508-1654 (M.S.); Fax: +351-22508-1449 (M.S.) Received: 14 May 2020; Accepted: 5 June 2020; Published: 6 June 2020 Abstract: Bacterial biofilms contribute to problems with preserving food hygiene, jeopardizing any conventional intervention method used by the food industry. Hence, the approach of using essential oil (EO) compounds effective in biofilm control has considerable merit and deserves in-depth research. In this study, the effect of selected EO compounds (eugenol, trans-cinnamaldehyde, citronellol, and terpineol) was assessed on Escherichia coli biofilm control by plate count, resazurin assay, and Syto® 9/PI (-/propidium iodide) staining coupled with flow cytometry (FCM) and confocal laser scanning microscopy (CLSM). The selected EO compounds effectively inhibited the growth of planktonic E. coli at low concentrations of 3–5 mM, revealing a high antimicrobial activity. EO compounds markedly interfered with biofilms too, with trans-cinnamaldehyde causing the most prominent effects. Its antibiofilm activity was manifested by a high reduction of cell metabolic activity (>60%) and almost complete reduction in biofilm cell culturability.
    [Show full text]
  • The Synthesis of Vanillin
    The synthesis of vanillin - learning about aspects of sustainable chemistry by comparing different syntheses La síntesis de la vainilla - aprendiendo sobre aspectos de química sostenible mediante la comparación de diferentes síntesis NICOLE GARNER1, ANTJE SIOL2 , INGO EILKS1 1 Institute for Science Education, University of Bremen, 2 Center for Environmental Research and Sustainable Technology, University of Bremen, Germany, [email protected] Abstract • Prevention This paper discusses one way of integrating the aspects of sustainable chemistry into • Atom Economy secondary and undergraduate chemistry education. Two different synthesis reactions • Less Hazardous Chemical Syntheses for vanillin are presented, which both use isoeugenol as the starting reagent. Whereas • Designing Safer Chemicals the first synthesis is performed using conventional chemistry techniques, second • Safer Solvents and Auxiliaries approach employs strategies inspired by sustainable chemistry. The discussion • Design for Energy Efficiency covers how comparison of these two experiments can aid in learning about selected • Use of Renewable Feedstocks sustainable chemistry principles. • Reduce Derivatives Key words: education for sustainable development, chemistry education, green • Catalysis chemistry, vanillin • Design for Degradation • Real-time Analysis for Pollution Prevention Resumen • Inherently Safer Chemistry for Accident Prevention Este artículo analiza una manera de integrar los aspectos de la química sostenible en la escuela secundaria y en bachillerato.
    [Show full text]
  • Electroanalysis May Be Used in the Vanillin Biotechnological Production
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Open Archive Toulouse Archive Ouverte OATAO is an open access repository that collects the work of Toulouse researchers and makes it freely available over the web where possible This is an author’s version published in: http://oatao.univ-toulouse.fr/20317 Official URL: https://doi.org/10.1007/s12010-013-0631-2 To cite this version: Giraud, William and Mirabel, Marie and Comtat, Maurice Electroanalysis may be used in the Vanillin Biotechnological Production. (2014) Applied Chemistry and Biotechnology, 172 (4). 1953-1963. ISSN 0273-2289 Any correspondence concerning this service should be sent to the repository administrator: [email protected] Electroanalysis may be used in the Vanillin Biotechnological Production William Giraud & Marie Mirabel & Maurice Comtat Abstract This study shows that electroanalysis may be used in vanillin biotechnological production. As a matter of fact, vanillin and some molecules implicated in the process like eugenol, ferulic acid, and vanillic acid may be oxidized on electrodes made of different materials (gold, platinum, glassy carbon). By a judicious choice of the electrochemical method and the experimental conditions the current intensity is directly proportional to the molecule concentrations in a range suitable for the biotechnological process. So, it is possible to imagine some analytical strategies to control some steps in the vanillin biotechnological production: by sampling in the batch reactor during the process, it is possible to determine out of line the concentration of vanillin, eugenol, ferulic acid, and vanillic acid with a gold rotating disk electrode, and low concentration of vanillin with addition of hydrazine at an amalgamated electrode.
    [Show full text]
  • Identification of Flavour Additives in Tobacco Products to Develop A
    Research paper Tob Control: first published as 10.1136/tobaccocontrol-2016-052961 on 11 February 2017. Downloaded from Identification of flavour additives in tobacco products to develop a flavour library Erna JZ Krüsemann, Wouter F Visser, Johannes WJM Cremers, Jeroen LA Pennings, Reinskje Talhout ► Additional material is ABStract flavoured tobacco products over unflavoured 2 published online only. To view Objectives This study combines chemical analysis products. Furthermore, Kreslake and colleagues please visit the journal online (http:// dx. doi. org/ 10. 1136/ and flavour descriptions of flavour additives used in analysed data from tobacco industry documents, tobaccocontrol- 2016- 052961). tobacco products, and provides a starting point to build which show that tobacco companies use strat- an extensive library of flavour components, useful for egies to manipulate sensory characteristics of National Institute for Public product surveillance. cigarettes, for instance the menthol content, to Health and the Environment Methods Headspace gas chromatography-mass facilitate smoking initiation.3 According to them, (RIVM), Bilthoven, The Netherlands spectrometry (GC-MS) was used to compare 22 this strategy has been most successful in attracting commercially available tobacco products (cigarettes youth and young adult smokers. Correspondence to and roll-your-own) expected to have a characterising Overall, tobacco products with a characterising Professor Reinskje Talhout, flavour and 6 commercially available products not flavour stimulate young people to initiate smoking National Institute for Public expected to have a characterising flavour with 5 and therefore contribute to an increased use of Health and the Environment reference products (natural tobacco leaves and research 1 4 (RIVM), Antonie van tobacco products. Leeuwenhoeklaan 9, 3721 MA cigarettes containing no flavour additives).
    [Show full text]
  • Bio-Based Thermosetting Copolymers of Eugenol and Tung Oil Harris Handoko Iowa State University
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2014 Bio-based thermosetting copolymers of eugenol and tung oil Harris Handoko Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Mechanics of Materials Commons, and the Polymer Chemistry Commons Recommended Citation Handoko, Harris, "Bio-based thermosetting copolymers of eugenol and tung oil" (2014). Graduate Theses and Dissertations. 13757. https://lib.dr.iastate.edu/etd/13757 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Bio-based thermosetting copolymers of eugenol and tung oil by Harris Handoko A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Material Science and Engineering Program of Study Committee: Samy Madbouly, Co-Major Professor Lawrence Genalo, Co-Major Professor Xiaoli Tan David Grewell Iowa State University Ames, Iowa 2014 Copyright © Harris Handoko, 2014. All rights reserved. ii TABLE OF CONTENTS LIST OF ABBREVIATIONS………………………………………………………………...... iv ACKNOWLEDGEMENT…………………………………………………………………..… vi ABSTRACT…………………………………………………………………………………..... vii CHAPTER 1: BACKGROUND INFORMATION 1.1
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0054021 A1 Dalko Et Al
    US 20030054021A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0054021 A1 Dalko et al. (43) Pub. Date: Mar. 20, 2003 (54) 7-OXO-DHEACOMPOUNDS FOR TREATING (30) Foreign Application Priority Data KERATINOUS CONDITIONS/AFFLICTIONS Jun. 14, 2001 (FR)............................................ 01/07804 (76) Inventors: Maria Dalko, Gif Sur Yvette (FR); Publication Classification Alexandre Cavezza, Tremblay-En-France (FR); Elisabeth (51) Int. Cl." ....................... A61K 31/695; A61K 31/66; Picard-Lesboueyries, Velizy (FR); A61K 31/58; A61K 31/56; Beatrice Renault, Saint Maurice (FR); A61K 7/OO Veronique Burnier, Paris (FR) (52) U.S. Cl. ............................ 424/401; 514/63; 514/172; 514/176; 514/177; 514/143 Correspondence Address: (57) ABSTRACT Norman H. Stepno, Esquire BURNS, DOANE, SWECKER & MATHIS, 7-Oxo-DHEA derivatives, various of which are themselves L.L.P. novel compounds, are well Suited for cosmetically/therapeu P.O. Box 1404 tically treating adverse conditions/afflictions of a keratinous Alexandria, VA 22313-1404 (US) Substrate/material, notably of human skin, hair, eyelashes and nails, to improve the appearance thereof, in particular to prevent or treat Signs of aging of the Skin and/or a dull (21) Appl. No.: 10/170,679 complexion and/or skin or hair pigmentation disorders and/ or dryneSS of the skin and/or hyperSeborrhoea and/or hyper Seborrhoea-related imperfections and/or Sensitive skin and/ (22) Filed: Jun. 14, 2002 or dandruff and/or natural hair loSS and/or baldness. US 2003/0054021 A1 Mar. 20, 2003 7-OXO-DHEACOMPOUNDS FOR TREATING KERATINOUS CONDITIONS/AFFLICTIONS (I) Me O CROSS-REFERENCE TO PRIORITY APPLICATION Me 0001.
    [Show full text]
  • Method of Preparing Vanillin
    (19) TZZ¥Z_T (11) EP 3 045 444 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 153(4) EPC (43) Date of publication: (51) Int Cl.: 20.07.2016 Bulletin 2016/29 C07C 47/58 (2006.01) (21) Application number: 15750614.8 (86) International application number: PCT/CN2015/085408 (22) Date of filing: 29.07.2015 (87) International publication number: WO 2016/000664 (07.01.2016 Gazette 2016/01) (84) Designated Contracting States: • LIU, Zhenjiang AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Jiaxing City, Zhejiang 314000 (CN) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • YAO, Yueliang PL PT RO RS SE SI SK SM TR Jiaxing City, Zhejiang 314000 (CN) Designated Extension States: • WANG, Chaoyang BA ME Jiaxing City, Zhejiang 314000 (CN) Designated Validation States: • WU, Jianxin MA Jiaxing City, Zhejiang 314000 (CN) • ZHAO, Feifei (30) Priority: 30.06.2014 CN 201410304472 Jiaxing City, Zhejiang 314000 (CN) (71) Applicant: JIAXING ZHONGHUA CHEMICAL CO., (74) Representative: Johnson, Richard Alan et al LTD. Mewburn Ellis LLP Nanhu District City Tower Jiaxing City, 40 Basinghall Street Zhejiang 314000 (CN) London EC2V 5DE (GB) (72) Inventors: Remarks: • MAO, Haifang A request for restoration of the right of priority under Jiaxing City, Zhejiang 314000 (CN) Rule 49ter.2 PCT is pending before the EPO as • WANG, Lizhi designated Office. Jiaxing City, Zhejiang 314000 (CN) (54) METHOD OF PREPARING VANILLIN (57) A method of preparing vanillin comprises weigh- water with the volume ratio of water to the first solvent ing eugenol, a strong alkali,
    [Show full text]
  • Eugenol—The Active Principle from Cloves Inhibits 5-Lipoxygenase Activity and Leukotriene-C4 in Human PMNL Cells
    ARTICLE IN PRESS Prostaglandins, Leukotrienes and Essential Fatty Acids 74 (2006) 23–27 www.elsevier.com/locate/plefa Eugenol—The active principle from cloves inhibits 5-lipoxygenase activity and leukotriene-C4 in human PMNL cells H. Raghavenraa, B.T. Diwakra, B.R. Lokeshb, K.A. Naidua,Ã aDepartment of Biochemistry and Nutrition, Central Food Technological Research Institute, Cheluvamba Mansion, Mysore, Karnataka 570 020, India bLipid Science and Traditional Foods, Mysore, Karnataka, India Received 30 June 2005; received in revised form 11 July 2005; accepted 11 August 2005 Abstract Polymorphonuclear leukocytes (PMNL) play an important role in the modulation of inflammatory conditions in humans. PMNL cells recruited at the site of inflammation, release inflammatory mediators such as leukotrienes, proteolytic enzymes and reactive oxygen species. Among these, leukotrienes are implicated in pathophysiology of allergic and inflammatory disorders like asthma, allergic rhinitis, arthritis, inflammatory bowel disease and psoriasis. 5-Lipoxygenase (5-LO) is the key enzyme in biosynthetic pathway of leukotrienes. Our earlier studies showed that spice phenolic active principles significantly inhibit 5-LO enzyme in human PMNLs. In this study we have further characterized the inhibitory mechanism of eugenol, the active principle of spice-clove on 5-LO enzyme and also its effect on leukotriene C4 (LTC4). Substrate dependent enzyme kinetics showed that the inhibitory effect of eugenol on 5-LO was of a non-competitive nature. Further, eugenol was found to significantly inhibit the formation of LTC4 in calcium ionophore A23187 and arachidonic acid (AA) stimulated PMNL cells. These data clearly suggest that eugenol inhibits 5-LO by non-competitive mechanism and also inhibits formation of LTC4 in human PMNL cells and thus may have beneficial role in modulating 5-LO pathway in human PMNL cells.
    [Show full text]
  • Efficacy of Benzocaine, Eugenol, and Menthol As Anesthetics for Freshwater Angelfish
    Journal of Aquatic Animal Health 30:210–216, 2018 © 2018 American Fisheries Society ISSN: 0899-7659 print / 1548-8667 online DOI: 10.1002/aah.10030 ARTICLE Efficacy of Benzocaine, Eugenol, and Menthol as Anesthetics for Freshwater Angelfish Rafael de Souza Romaneli, Andre Zuffo Boaratti, Andressa Tellechea Rodrigues, Daniel Monge de Almeida Queiroz, Kifayat Ullah Khan, Thiago Matias Torres Nascimento, and Joao~ Batista Kochenborger Fernandes Aquaculture Center, Sao~ Paulo State University, Via de Acesso Paulo Donato Castellane s/n, 14884-900 Jaboticabal, Sao~ Paulo, Brazil Cleber Fernando Menegasso Mansano* Campus Fernandopolis, Brazil University, Estrada Projetada F-1, s/n Fazenda Santa Rita, 15600-000 Fernandopolis, Sao~ Paulo, Brazil Abstract For the production and commercialization of ornamental fish species, it is indispensable to collect biometric data that facilitate the selection of animals for trade and genetic improvement of the stock. However, during the handling process, fish receive more stress if proper anesthetics are not used. Thus, application of appropriate anesthetics is an important tool for minimizing stress in animals. The objective of this study was to determine the effective concentra- tions of benzocaine, eugenol, and menthol for achieving anesthesia in Freshwater Angelfish Pterophyllum scalare and to develop induction and recovery response curves for different concentrations of these anesthetics. In total, 75 fish were exposed to five concentrations of the three anesthetics in a completely randomized design: benzocaine at 60, 85, 110, 135, and 160 mg/L; eugenol at 40, 80, 120, 160, and 200 mg/L; and menthol at 50, 75, 150, 200, and 250 mg/L. Each concentration (5 fish/concentration) consisted of five replicates, with each replicate represented by a single fish.
    [Show full text]
  • Caryophylli-Aetheroleum-Summary-Report-Committee-Veterinary-Medicinal-Products En.Pdf
    The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/406/98-FINAL May 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS CARYOPHYLLI AETHEROLEUM SUMMARY REPORT 1. Caryophylli aetheroleum is the volatile oil of the flower buds of Syzygium aromaticum (L.) Merr. & Perry (synonym: cloves), which contain 15 to 18% of the oil. The oil contains: eugenol (80 to 90%), eugenyl acetate (2 to 27%), ß-caryophyllene (5 to 12%), methyl salicylate, methyl eugenol, benzaldehyde, methyl amyl keton and a-ylangene. 2. Caryophylli aetheroleum is contained in two veterinary medicinal combination products containing 9 and 6 other active ingredients, respectively. The concentration of Caryophylli aetheroleum in the first product is 0.008%. It is administered as a nose-spray to newborn of all food producing species as a respiratory stimulant. The dose ranges from 0.1 g to 0.3 g, depending on body weight. The maximum single dose of Caryophylli aetheroleum is 0.024 mg. The treatment may be repeated after 10 to 15 seconds. In the other product, Caryophylli aetheroleum is contained in a concentration of 0.5%. The oinment is used for disinfection of the udder and to prevent transmission of diseases of the udder of cattle, horses, goats, sheep, and pigs. The ointment is used as frequently as is required. Caryophylli aetheroleum is traditionally used orally in human medicine as a carminative, and occasionally for the treatment of flatulent colic, and topically for symptomatic relief of toothache. The doses used are 0.05 to 0.2 ml. Cloves, which contain Caryophylli aetheroleum, are used as a spice and for flavouring of food.
    [Show full text]